Q&A

The Changing Oncology Landscape

Source: Medpace
The Changing Oncology Landscape

Dr. Franklin Smith, Medpace’s vice president of medical affairs and specialist in hematology oncology, reflects on advances in oncology drug development. Read his insights on how the landscape for oncology treatment changed, given the breakthroughs in cancer immunotherapy and precision medicine as well as key challenges in designing protocols for oncology studies and how those protocols will impact advances in oncology drug development.

VIEW THE Q&A!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: